CTRI/2018/03/012413招募中未知
Comparative efficacy of Sitagliptin and Teneligliptin as add on therapy to Metformin in type 2 diabetes mellitus patients.
Department of Pharmacology and Therapeutics0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with 18-70 years of age.
- •2. Newly diagnosed patients with Type-2 Diabetes Mellitus.
- •a. Patients with an HBA1c value above or equal to 6.5 percent. OR
- •b. Patients with fasting glucose above or equal to 126 mg/dl.OR
- •c. Patients with 2-hour glucose, following ingestion of 75 g glucose load, above or equal to 200 mg. OR
- •d. Symptomatic patients with random plasma glucose above or equal to 200 mg.
排除标准
- •1. Patients with Type - 1 Diabetes Mellitus
- •2. Patients with a history of severe diabetic complications: Ketoacidosis, Retinopathy, Nephropathy, Neuropathy.
- •3. Hypersensitivity to any of the used drugs.
- •4. Pregnant and lactating females
- •5. Liver and kidney dysfunction or severe anemia
- •6. Patients with serious cardiovascular disease (NYHA class I-IV CHF or history of MI or stroke) or cerebrovascular conditions within 6 months before enrolment.
研究者
相似试验
已完成
不适用
Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetesType 2 diabetesJPRN-UMIN000022885niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine20
已完成
不适用
Comparison of effect of sitagliptin and nateglinide on postprandial glucose level and secretion of insulin and glucagon after meal tolerance test in early type 2 diabetesearly type 2 diabetesJPRN-UMIN000005376Juntendo University Graduate School of Medicine20
已完成
不适用
Efficacy and Safety comparison of Sitagliptin and Glimepiride in elderly Japanese patients with type 2 diabetestype 2 diabetesJPRN-UMIN000004047Japan Association for Diabetes Education and Care900
已完成
2 期
Sitagliptin and Pioglitazon effects in the treatment of diabetesIRCT2015061619554N4Vice chancellor for research; Zanjan University of Medical Sciences160
已完成
不适用
Comparison of effectiveness of sitagliptin and nateglinide in type 2 diabetes.type 2 diabetesJPRN-UMIN000006278Japanese Red Cross Medical Center40
